Drug Companies Face Hostility as They Hope for Allies Among Trump’s Health Picksnews2024-11-28T02:32:29+00:00November 28th, 2024|The New York Times|
U.S. Scrutiny of Chinese Company Could Disrupt U.S. Supply Chain for Key Drugsnews2024-04-15T19:47:14+00:00April 15th, 2024|The New York Times|
How Vivek Ramaswamy Made the Fortune Fueling His Presidential Runnews2023-06-27T14:23:59+00:00June 27th, 2023|The New York Times|
Can Africa Get Close to Vaccine Independence? Here’s What It Will Take.news2023-04-25T15:39:50+00:00April 25th, 2023|The New York Times|
When the Horseshoe Crabs Are Gone, We’ll Be in Troublenews2023-02-16T14:41:17+00:00February 16th, 2023|The New York Times|
Scientists Question Data Behind an Experimental Alzheimer’s Drugnews2022-04-19T00:48:52+00:00April 19th, 2022|The New York Times|
Democrats Choosing Less Risky Path on Drug Pricesnews2021-11-06T07:00:07+00:00November 6th, 2021|The New York Times|
Here’s Why Developing Countries Can Make mRNA Covid Vaccinesnews2021-10-23T01:56:09+00:00October 23rd, 2021|The New York Times|
